Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Viking Thera
(NQ:
VKTX
)
50.10
+0.26 (+0.52%)
Official Closing Price
Updated: 4:15 PM EDT, Jul 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
2,600,152
Open
51.08
Bid (Size)
50.27 (1)
Ask (Size)
50.39 (3)
Prev. Close
49.84
Today's Range
48.53 - 51.68
52wk Range
8.280 - 99.41
Shares Outstanding
99,581,693
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
EXCLUSIVE: Weight-Loss Duopoly Breaks As Eli Lilly, Novo Plummet; 'Market Won't Be Dominated By Just 2 Players'
Today 16:59 EDT
Eli Lilly and Novo Nordisk face selloff as new weight-loss drugs threaten dominance. Shares of both companies drop significantly, highlighting need for diversification in this industry.
Via
Benzinga
Smart Money Is Betting Big In VKTX Options
Today 13:01 EDT
Via
Benzinga
Performance
YTD
+174.07%
+174.07%
1 Month
-1.07%
-1.07%
3 Month
-22.53%
-22.53%
6 Month
+139.26%
+139.26%
1 Year
+229.17%
+229.17%
More News
Read More
3 Biotech Stocks That Could Be Multibaggers in the Making: July Edition
Today 7:00 EDT
Via
InvestorPlace
Obesity-Drugs Focused Stocks Tumble On Wednesday - What's Going On With Eli Lilly, Novo Nordisk, Viking Therapeutics, Structure Therapeutics?
July 17, 2024
Via
Benzinga
Jim Cramer Says Don't Sell Match Group: 'You've Just Got A Very, Very Smart Investor In There'
July 17, 2024
Via
Benzinga
Spotlight on Viking Therapeutics: Analyzing the Surge in Options Activity
July 05, 2024
Via
Benzinga
Here's How Much $1000 Invested In Viking Therapeutics 5 Years Ago Would Be Worth Today
July 01, 2024
Via
Benzinga
Why ASLAN Pharmaceuticals Shares Are Trading Lower By Over 38%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
July 17, 2024
Via
Benzinga
Eli Lilly, Novo Nordisk Fall As Roche Releases Weight-Loss Drug Data
July 17, 2024
Via
Investor's Business Daily
Is Viking Therapeutics the Best Biotech Stock for You?
July 17, 2024
Via
The Motley Fool
The 3 Most Undervalued Biotech Stocks to Buy in July 2024
July 12, 2024
Via
InvestorPlace
Is Viking Therapeutics Stock Running Out of Steam?
July 11, 2024
Via
The Motley Fool
Better GLP-1 Biotech Stock: Altimmune vs. Viking Therapeutics
July 10, 2024
Via
The Motley Fool
Eli Lilly Stock Leads in GLP-1 Race with its Triple Agonist Drug
July 09, 2024
Via
MarketBeat
Eli Lilly Rose More Than 50% So Far This Year. Can It Soar Past $1,000 in the 2nd Half?
July 09, 2024
Via
The Motley Fool
3 Overlooked Giants-in-the-Making for Patient Investors
July 08, 2024
Via
InvestorPlace
The 7 Best Under $10 Stocks to Buy in July 2024
July 06, 2024
Via
InvestorPlace
Forget Eli Lilly: 3 Biotech Stocks to Buy Instead
July 04, 2024
Via
The Motley Fool
S&P 500, Nasdaq 100 Climb To Record Highs As Data Fosters Rate Cut Optimism Ahead Of Fed Minutes; Gold, Bonds Rally: What's Driving Markets Wednesday?
July 03, 2024
Via
Benzinga
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
3 Biotech Moonshots With Imminent Catalyst Potential
July 03, 2024
Via
InvestorPlace
Altimmune Stock: Is Its GLP-1 Drug the Next Ozempic Killer?
July 03, 2024
Via
MarketBeat
Exposures
Product Safety
Pfizer Stock is Ready to Stage a Turnaround on GLP-1 Hopes
July 02, 2024
Via
MarketBeat
Eli Lilly Stock Up: GLP-1 Zepbound Targets Sleep Apnea Market
July 01, 2024
Via
MarketBeat
Exposures
Product Safety
Viking Therapeutics Stock Is Up by 154% Since January -- Can It Double Again in the Second Half of the Year?
July 01, 2024
Via
The Motley Fool
3 Reasons Why Altimmune Stock Could Be the Next Viking Therapeutics
June 30, 2024
Via
The Motley Fool
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.